In AS setting, within the above-mentioned multi-institutional Canary Prostate AS Study (n = 387) [43], TMPRSS2:ERG score was also significantly associated with higher biopsy Gleason score and tumor volume, assessed by the percentage of positive cores, in subsequent biopsies (P < 0.01 for all comparisons). The gene discussed is TMPRSS2; the disease is neoplasm.